Skip to main content
Redcare Pharmacy N.V. logo

Redcare Pharmacy N.V. — Investor Relations & Filings

Ticker · SAE ISIN · NL0012044747 LEI · 529900JK6UXHY1YKZ082 F Wholesale and retail trade
Open in API
Filings indexed 682 across all filing types
Latest filing 2026-05-06 Interim / Quarterly Rep…
Country NL Netherlands
Listing F SAE

About Redcare Pharmacy N.V.

https://www.redcare-pharmacy.com/about-…

Redcare Pharmacy N.V. is a leading European online pharmacy, formerly operating under the name Shop Apotheke Europe. The company functions as a one-stop pharmacy, offering a comprehensive assortment of over 150,000 products. Its portfolio includes over-the-counter (OTC) medications, nutritional supplements, beauty and personal care products, and a wide range of other health-related items. Serving more than 12 million active customers across multiple European markets, Redcare Pharmacy integrates digital services with pharmaceutical expertise to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Redcare Pharmacy starts 2026 with a strong topline performance and a 58% increase of adj. EBITDA.
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement dated May 6, 2026, reporting Redcare Pharmacy's financial performance for the first quarter of 2026. It includes comprehensive financial data such as revenue growth, adjusted EBITDA, segment performance, and guidance for the full year 2026. The presence of actual financial figures, analysis of business segments, and management commentary indicates this is a substantive financial report for a period shorter than a full fiscal year. The document is not merely an announcement of a report publication but contains the financial results themselves. The content aligns with the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-06 English
Q1 statement / Q1 financial report 2026
Interim / Quarterly Report Classification · 98% confidence The document is titled 'Interim report' and dated March 31, 2026, indicating it covers a period shorter than a full fiscal year (Q1 2026). It contains detailed financial statements such as consolidated statement of profit and loss, statement of financial position, cash flow, segment performance, and management commentary on business development, risk management, and forecasts. The length is substantial (15,000 characters) and includes actual financial data and analysis, not just an announcement or summary. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year with substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. Q1 2026
2026-05-06 English
Presentation Earnings Call Q1 2026
Earnings Release Classification · 95% confidence The document is an earnings call presentation for Q1 2026 by Redcare Pharmacy. It includes detailed financial performance data, segment revenue breakdowns, margin analysis, regulatory updates, and guidance for the year. The presence of Q&A and the focus on quarterly financial results and operational highlights are typical of earnings call presentations. The document is about 7,800 characters, which is consistent with a presentation rather than a full report. It explicitly states it is an 'Earnings call presentation' and includes slides with financial metrics and guidance. Therefore, the document fits the category of an Earnings Release (ER) type filing, which covers initial announcements of quarterly financial results and key highlights. Q1 2026
2026-05-06 English
Redcare Pharmacy: Dirk Brüse to step down as CCO.
Board/Management Information Classification · 91% confidence The document is a corporate announcement stating that the Chief Commercial Officer is stepping down and the CEO will assume responsibilities until a successor is found. This is a notice of a change in senior management, matching the category for Board/Management Information (MANG).
2026-04-29 English
Change in Redcare Pharmacys Managing Board: Dirk Bruse to step down as CCO.
Board/Management Information Classification · 98% confidence The document is a corporate news release announcing a change in the company’s managing board, specifically the CCO stepping down and succession plans. This falls squarely under Board/Management Information.
2026-04-28 English
Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.
Regulatory Filings Classification · 75% confidence The text is a corporate press release via EQS News announcing a new technology adoption by Redcare Pharmacy. It does not contain financial results (earnings), management changes, capital events, dividends, legal proceedings, governance materials, or any formal report; it is a general corporate announcement. There is no reference to a specific filing form or attachment, and the content is purely descriptive of operational improvements. This falls into the fallback category of general regulatory announcements. Therefore, it should be classified as RNS.
2026-04-22 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.